Stock Screener - US Stocks, Forex and ETFs Please enable JavaScript to view this page content properly  
     
   MACD(12,26,9) Crossed Below Signal Line     
Criteria:
MACD(12,26,9) Crossed Below Signal Line
  Back to MACD Stock Screener
           
   Symbol   Name   Industry   Sector   Exchange  Cap, mln  Last  Change  Change, %  Volume
 AA   Alcoa Corp  Aluminum Basic Materials NYSE 10,230  51.95  1.13 2.2 4,743,668
 AABA   Altaba Inc  Asset Management Financial NASDAQ 57,160  68.27  -0.99 -1.4 4,136,934
 AADR   Advisorshares Dorsey Wright ADR  Exchange Traded Fund Financial NYSE 261  57.94  -1.01 -1.7 15,084
 ABAX   Abaxis Inc  Medical Laboratories & Research Healthcare NASDAQ 1,640  70.86  -1.58 -2.2 147,900
 ABE   Aberdeen EM Smaller Company Fund  Closed End Funds Financial NYSE 141  14.64  -0.08 -0.5 3,169
 ABEO   Abeona Therapeutics  Biotechnology Healthcare NASDAQ 933  17.30  -1.15 -6.2 1,229,176
 ACAD   Acadia Pharmaceutica  Biotechnology Healthcare NASDAQ 2,360  15.20  -4.27 -21.9 18,072,310
 ACIW   Aci Worldwide Inc  Technical & System Software Technology NASDAQ 2,810  24.03  -0.20 -0.8 489,526
 ACM   Aecom Technology Corp  Technical Services Services NYSE 5,730  35.49  -0.21 -0.6 707,261
 ACWF   Ishares Global Multifactor ETF  Exchange Traded Fund Financial NYSE 48  30.558  -0.13 -0.4 6,848
Please sign up for viewing the full list of stocks


Education MACD - Technical Analysis from A to Z
The MACD (Moving Average Convergence/Divergence) is a trend following momentum indicator that shows the relationship between two moving averages of prices. The MACD is the difference between a 26-day and 12-day exponential moving average. A 9-day exponential moving average, called the "signal" line is plotted on top of the MACD to show buy/sell opportunities. The MACD proves most effective in wide-swinging trading markets. There are three popular ways to use the MACD: crossovers, overbought/oversold conditions, and divergences. Learn more




Disclaimer - FAQ - Contact Us
Copyright ©2008-2018 MarketInOut.com. All rights reserved.
Best viewed in